You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-Cov-2

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Kansas City (The-Optimal-Lymph-Flow (TOLF) Program)

Not yet recruiting
  • Breast Cancer
  • The-Optimal-Lymph-Flow (TOLF) Program
  • Kansas City, Missouri
    University of Missouri-Kansas City
Nov 17, 2023

Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)

Active, not recruiting
  • Sickle Cell Disease
  • Oakland, California
  • +34 more
Sep 21, 2022

Platinum-resistant Epithelial Ovarian Cancer Trial in Ocala, Mineola (Maveropepimut-S, Cyclophosphamide 50mg)

Recruiting
  • Platinum-resistant Epithelial Ovarian Cancer
  • Maveropepimut-S
  • Cyclophosphamide 50mg
  • Ocala, Florida
  • +1 more
Jul 20, 2022

Type 1 Diabetes Trial in Montreal (Physical activity trial intervention)

Not yet recruiting
  • Type 1 Diabetes
  • Physical activity trial intervention
  • Montreal, Quebec, Canada
    Institut de recherches cliniques de Montréal
Apr 6, 2023

Diabetes, Type 2, Obesity Trial in Columbia (Dietary Intervention Classes)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Obesity
  • Dietary Intervention Classes
  • Columbia, South Carolina
    University of South Carolina
May 4, 2022

Relapsed/Refractory Multiple Myeloma Trial in Louisville, Boston (agenT-797)

Active, not recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Louisville, Kentucky
  • +2 more
Oct 21, 2022

Immune-Mediated Necrotizing Myopathy Trial in Seattle (Gamunex-C, Albumin)

Withdrawn
  • Immune-Mediated Necrotizing Myopathy
  • Seattle, Washington
    University of Washington
Oct 19, 2022

Gamification, Type 2 Diabetes, Self-management Trial in Istanbul (Gamification and education with mobile game application)

Recruiting
  • Gamification
  • +4 more
  • Gamification and education with mobile game application
  • Istanbul, Sisli, Turkey
    Pelin ILHAN
Feb 2, 2023

Acne Vulgaris Trial in Islamabad (D Max Drops, Azithromycin 250 milligram Oral Capsule, Adapalene)

Not yet recruiting
  • Acne Vulgaris
  • D Max Drops
  • +2 more
  • Islamabad, Punjab, Pakistan
    Hitec-Ims
Nov 19, 2023

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Epilepsy Trial in Spain, United Kingdom (GWP42003-P 20 mg/kg/Day Dose, Placebo, Clobazam)

Completed
Has Results
  • Epilepsy
  • GWP42003-P 20 mg/kg/Day Dose
  • +2 more
  • Barcelona, Spain
  • +5 more
Sep 22, 2022

NAFLD Pediatric Database 2

Completed
  • Liver Disease
    • San Diego, California
    • +11 more
    Feb 7, 2022

    Relapsed/Refractory Multiple Myeloma Trial in Worldwide (BGB-11417, Dexamethasone, Carfilzomib)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Birmingham, Alabama
    • +21 more
    Aug 8, 2022

    Maternal Behavior, Alcohol Drinking, Fetal Conditions Trial (Intervention with contingent incentives and text-based support)

    Not yet recruiting
    • Maternal Behavior
    • +2 more
    • Intervention with contingent incentives and text-based support
    • (no location specified)
    Feb 17, 2023

    Post Operative Pain Trial in Cairo (surgical rectus sheath block, subdermal local anaesthetic infiltration)

    Not yet recruiting
    • Post Operative Pain
    • surgical rectus sheath block
    • subdermal local anaesthetic infiltration
    • Cairo, El Manial, Egypt
      The Obstetrics and Gynecology department of Kasr Alainy Universi
    Aug 30, 2023

    Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule

    Recruiting
    • Drug-Induced Liver Injury
    • +2 more
    • MT2004 Capsule
    • MT2004 Capsule Placebo
    • Shanghai, Shanghai, China
      Shanghai Jiaotong University School of Medicine,Renji Hospital
    Aug 25, 2023

    Metabolic Biomarkers and Their Prognostic Relationship in

    Not yet recruiting
    • Ovarian Cancer
    • No intervention
    • (no location specified)
    Aug 24, 2023

    Irritable Bowel Syndrome (IBS) Trial in Nanjing (DAO supplement, Placebo)

    Not yet recruiting
    • Irritable Bowel Syndrome (IBS)
    • DAO supplement
    • Placebo
    • Nanjing, Jiangsu, China
      Zhenyu Zhang
    Nov 15, 2023

    Moderate to Severe Atopic Dermatitis Trial in United States (Rezpegaldesleukin, Placebo)

    Recruiting
    • Moderate to Severe Atopic Dermatitis
    • Los Angeles, California
    • +4 more
    Nov 13, 2023

    Crohn Disease Trial in Liège (EXL01, Placebo, SoC corticosteroid - Induction Period)

    Not yet recruiting
    • Crohn Disease
    • Liège, Belgium
      CHU de Liege
    Sep 13, 2022

    Point-of-care Low-field MRI in Acute Stroke

    Not yet recruiting
    • Stroke
    • +3 more
    • Portable low-field MRI
    • Avezzano, Abruzzo, Italy
    • +3 more
    Apr 15, 2023

    Plasma Proteomics in Patients With Postoperative Delirium

    Not yet recruiting
    • Postoperative Delirium
      • (no location specified)
      Mar 5, 2023

      Mobile Applications, Pain, Postoperative, Smartphone Trial in Seoul (A new smart device application (Smart APS))

      Recruiting
      • Mobile Applications
      • +3 more
      • A new smart device application (Smart APS)
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Aug 29, 2023

      Health Behavior Trial in Leeds (Volitional help sheet, Control condition)

      Recruiting
      • Health Behavior
      • Volitional help sheet
      • Control condition
      • Leeds, United Kingdom
        The University of Leeds
      Apr 18, 2023

      HIV/AIDS, Young Adult, Mobile Health Trial in San Francisco (Standard of Care, Video-counseling+app)

      Not yet recruiting
      • HIV/AIDS
      • +4 more
      • Standard of Care
      • Video-counseling+app
      • San Francisco, California
        Division of Prevention Science, Center for AIDS Prevention Studi
      May 17, 2023